Development of a machine learning-based prediction model for serious bacterial infections in febrile young infants

开发基于机器学习的预测模型,用于预测发热婴幼儿的严重细菌感染

阅读:1

Abstract

BACKGROUND: To develop and validate machine learning (ML)-based models to predict serious bacterial infections (SBIs) in febrile infants aged ≤90 days. METHODS: This retrospective study analysed data from febrile infants (≥38.0℃) aged ≤90 days. The development dataset comprised data from patients who visited the Seoul Asan Medical Center between 2015 and 2021, whereas the validation dataset included data from those who visited the centre from January 2022 to August 2023. Logistic regression (LR) and eXtreme Gradient Boosting (XGB) were used to develop the models for predicting SBIs, which were then compared with traditional rule-based models. RESULTS: The study included data from 2860 patients: 2288 (80%) in the development dataset and 572 (20%) in the validation dataset. SBIs were confirmed in 482 patients (21.0%) in the development dataset and 131 (22.9%) in the validation dataset. The XGB and LR models showed excellent performance with areas under the curve of 0.990 and 0.981 in development, and 0.989 and 0.985 in validation datasets. In validation, both models demonstrated superior specificity (82.3-87.0% vs 46.2-72.2%) and positive predictive value (61.5-68.5% vs 34.4-49.8%) compared with traditional rule-based models, while maintaining perfect sensitivity and negative predictive value (both 100% vs 81.7-100% and 92.0-100%, respectively) without any false negatives. Urinalysis, C-reactive protein and procalcitonin were identified as top-tier features in the XGB model. CONCLUSIONS: The ML-based prediction model demonstrated robust performance, with superior specificity and perfect sensitivity, which may enhance the accuracy of SBI detection and reduce the costs associated with false positives.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。